World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
89
Citations
25438
World Ranking
2210
National Ranking
10

Karel Ulbrich publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Karel Ulbrich sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 322 publications — 68th percentile

68% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Karel Ulbrich D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Karel Ulbrich sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 89 D-Index — 88th percentile

88% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Karel Ulbrich was a researcher affiliated with the Czech Academy of Sciences in the Czech Republic. Their academic contributions and research activities were primarily associated with this institution.

Throughout their career, Ulbrich's work was documented, but there is no available detailed record of specific publications, papers, or authored books. Likewise, there is no data on frequent collaborative partners or predominant publication venues tied to their research.

The scientific domains and focus areas of Karel Ulbrich remain unspecified, as there is no detailed information about their main or subfields of study, nor the specific topics they addressed in their research.

No known awards or honors are recorded in relation to their career, and the exact timeline of their professional activities is not indicated beyond the fact that they are deceased.

This profile is based on the available data, reflecting only the confirmed affiliations and the absence of additional academic records or recognized distinctions linked to their name.

Best Publications

  • Targeted Drug Delivery with Polymers and Magnetic Nanoparticles: Covalent and Noncovalent Approaches, Release Control, and Clinical Studies.

    Karel Ulbrich;Kateřina Holá;Vladimir Šubr;Aristides Bakandritsos

  • Polymeric anticancer drugs with pH-controlled activation.

    Karel Ulbrich;Vladimír Subr

  • Early Phase Tumor Accumulation of Macromolecules: A Great Difference in Clearance Rate between Tumor and Normal Tissues

    Youichiro Noguchi;Jun Wu;Ruth Duncan;Jiří Strohalm

  • Characterization of Vectors for Gene Therapy Formed by Self-Assembly of DNA with Synthetic Block Co-Polymers

    Margreet A. Wolfert;Etienne H. Schacht;Veska Toncheva;Karel Ulbrich

  • Polymeric micellar pH-sensitive drug delivery system for doxorubicin.

    Martin Hrubý;Čestmír Koňák;Karel Ulbrich

  • Polymeric drugs based on conjugates of synthetic and natural macromolecules. I. Synthesis and physico-chemical characterisation.

    Ulbrich K;Subr;Strohalm J;Plocová D

  • INFLUENCE OF MOLECULAR WEIGHT ON PASSIVE TUMOUR ACCUMULATION OF A SOLUBLE MACROMOLECULAR DRUG CARRIER

    L.W. Seymour;Y. Miyamoto;H. Maeda;M. Brereton

  • New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties.

    Tomas Etrych;Markéta Jelinkova;Blanka Rihova;Karel Ulbrich

  • Novel vectors for gene delivery formed by self-assembly of DNA with poly(L-lysine) grafted with hydrophilic polymers.

    Veska Toncheva;Margreet A Wolfert;Philip R Dash;David Oupicky

  • Importance of lateral and steric stabilization of polyelectrolyte gene delivery vectors for extended systemic circulation

    David Oupicky;Manfred Ogris;Kenneth A. Howard;Philip R. Dash

  • Polyelectrolyte vectors for gene delivery: influence of cationic polymer on biophysical properties of complexes formed with DNA.

    Margreet A. Wolfert;Philip R. Dash;Ola Nazarova;David Oupicky

  • Passive versus active tumor targeting using RGD- and NGR-modified polymeric nanomedicines

    Sijumon Kunjachan;Robert Pola;Felix Gremse;Benjamin Theek

  • Poly(ethylene glycol) multiblock copolymer as a carrier of anti-cancer drug doxorubicin.

    Michal Pechar;Karel Ulbrich;Vladimír Šubr;Leonard W. Seymour

  • Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin.

    Marina Talelli;Maryam Iman;Amir K. Varkouhi;Cristianne J.F. Rijcken

  • Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers

    Twan Lammers;Twan Lammers;Vladimir Subr;Karel Ulbrich;Peter Peschke

  • Biocompatibility of N-(2-hydroxypropyl) methacrylamide copolymers containing adriamycin. Immunogenicity, and effect on haematopoietic stem cells in bone marrow in vivo and mouse splenocytes and human peripheral blood lymphocytes in vitro.

    B Rihova;M Bilej;V Vetvicka;K Ulbrich

  • Structural and chemical aspects of HPMA copolymers as drug carriers.

    Karel Ulbrich;Vladimír Šubr

  • HPMA copolymers with pH-controlled release of doxorubicin: in vitro cytotoxicity and in vivo antitumor activity.

    K. Ulbrich;T. Etrych;P. Chytil;M. Jelinkova

  • Extended plasma circulation time and decreased toxicity of polymer-coated adenovirus.

    N K Green;C W Herbert;S J Hale;A B Hale

  • Physical properties and in vitro transfection efficiency of gene delivery vectors based on complexes of DNA with synthetic polycations.

    Tomáš Reschel;Čestmı́r Koňák;David Oupický;David Oupický;Leonard W. Seymour

Frequent Co-Authors

Tomáš Etrych
Tomáš Etrych Czech Academy of Sciences
Twan Lammers
Twan Lammers RWTH Aachen University
Leonard W. Seymour
Leonard W. Seymour University of Oxford
Ruth Duncan
Ruth Duncan Cardiff University
Jindřich Kopeček
Jindřich Kopeček University of Utah
Hiroshi Maeda
Hiroshi Maeda Kumamoto University
Gert Storm
Gert Storm Utrecht University
Wim E. Hennink
Wim E. Hennink Utrecht University
Etienne Schacht
Etienne Schacht Ghent University
Fabian Kiessling
Fabian Kiessling RWTH Aachen University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Chemistry in the USA opens doors to diverse career pathways, many of which can be supplemented by online degrees. For example, aspiring paralegals with a focus on legal aspects of pharmaceuticals might explore an paralegal salary associate's degree program to jumpstart their career with practical knowledge and competitive earnings.

Another promising route is becoming a pharmaceutical sales representative. Understanding chemistry enhances product knowledge, which can boost success in this role. To learn more about the financial prospects and how to enter this field, check out the insights about pharmaceutical rep salary and career paths.

For those interested in clinical applications, becoming a pharmacist is a natural progression. However, it’s important to consider the investment involved, especially regarding how much does it cost to become a pharmacist—a crucial factor in planning your education and career goals.

Chemistry graduates may also pursue specialized roles such as an autopsy technician, combining scientific expertise with hands-on investigative work. Understanding the required education, salary, and job outlook through resources about autopsy technician careers can guide informed decisions.

Best Scientists Citing Karel Ulbrich

Recently Published Articles